Exploring a combination of VDAs and epidermal growth factor receptor (EGFR) inhibitors theoretically could also be an interesting approach; here one could speculate that tumour cells in the viable rim will become apoptotic and die when being deprived of their growth-stimulating factors such as EGF. This evidence concerns the gene EGFR and neoplasm.